Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | FAAH | O00519 | 4/20 | 0.57 |
| ▸ | DGKA | P23743 | 1/20 | 0.56 |
| ▸ | NAAA | Q02083 | 2/20 | 0.56 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.54 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.52 |
| ▸ | ACHE | P22303 | 6/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7724543 | 0.95 | L3MBTL1 (0.65) | CASP2L3MBTL1FAAHDGKANAAA | |
| SCHEMBL20903685 | 0.95 | L3MBTL1 (0.65) | CASP2L3MBTL1FAAHDGKANAAA | |
| SCHEMBL7737177 | 0.95 | L3MBTL1 (0.65) | CASP2L3MBTL1FAAHDGKANAAA | |
| SCHEMBL9801606 | 0.95 | L3MBTL1 (0.65) | CASP2L3MBTL1FAAHDGKANAAA | |
| SCHEMBL21467745 | 0.92 | L3MBTL1 (0.65) | CASP2L3MBTL1FAAHDGKANAAA | |
| SCHEMBL21468095 | 0.92 | L3MBTL1 (0.65) | CASP2L3MBTL1FAAHDGKANAAA | |
| SCHEMBL21468101 | 0.92 | L3MBTL1 (0.65) | CASP2L3MBTL1FAAHDGKANAAA | |
| SCHEMBL7155471 | 0.92 | DGKA (0.62) | CASP2L3MBTL1FAAHDGKANAAA | |
| SCHEMBL14213380 | 0.91 | L3MBTL1 (0.60) | CASP2L3MBTL1FAAHDGKANAAA | |
| SCHEMBL7150709 | 0.90 | DGKA (0.59) | CASP2L3MBTL1FAAHDGKANAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210196584-A1 | NOVEL COMPLEX AND EMULSION COMPOSITION | KOKYU ALCOHOL KOGYO CO., LTD. (JP) | 2021-07-01 | — | — | US | disclosed |
| US-20170018722-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2017-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170018722-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | EFNA1, TTI1, TERT | CASP2 4515/4885L3MBTL1 1372/4885FAAH 4625/4885 |
| US-20210196584-A1 | NOVEL COMPLEX AND EMULSION COMPOSITION | ADH5, LIPC, NCAPD2 | CASP2 4798/4885L3MBTL1 4710/4885FAAH 118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.